Stockreport

Eli Lilly's weight-loss drug succeeds in trials with sleep apnea patients [Reuters]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF , opens new tab weight-loss drug succeeded in two late-stage trials testing it in patients with obstructive sleep apnea, the company said on Wednesday. The drug, chem [Read more]